Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03311776 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

BIOmarkers in Patients With Pancreatic Cancer ("BIOPAC")

Study acronym: BIOPAC
StatusRecruiting
PhaseNot specified
Started2008-07-03
View on ClinicalTrials.gov ↗
No validated biomarkers to identify PC at an early stage and to predict treatment outcomes in the individual patient exist. The objective of the present study is to find diagnostic, prognostic and predictive biomarkers.

Amendment record

Amended 3 times since 2017-10-11; most recent filed 2023-02-28. Every amendment is listed below.

Dates here are the day the sponsor filed the amendment, not the day ClinicalTrials.gov published it. Version history last read from ClinicalTrials.gov on 2026-08-30.

2023-02-28
Amendment Study Status v3
2021-08-23
Amendment Study Status v2
2020-06-17
Amendment Study Status, Sponsor/Collaborators v1
2017-10-11
Original filing
Trial Details
NCT Number NCT03311776
Lead Sponsor Inna Chen, MD
Conditions Pancreatic Cancer
Enrollment 5,000 participants
Start Date 2008-07-03
Primary Completion 2035-07-02 (estimated)
Study Completion 2035-07-02 (estimated)
Updated on ClinicalTrials.gov 2023-03-01